These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17361)

  • 1. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Neuroscience; 1978; 3(9):773-83. PubMed ID: 30919
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinsonism induced by dopaminergic antagonists.
    Hornykiewicz O
    Adv Neurol; 1975; 9():155-64. PubMed ID: 1096571
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
    Aksent'ev SB; Mokhovikov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
    Arushanian EB
    Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacotherapy of schizophrenia.
    Ban TA
    Curr Psychiatr Ther; 1976; 16():163-75. PubMed ID: 991627
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evidence for multiple dopamine receptors in man.
    Meltzer HY
    Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].
    Costentin J
    Encephale; 1979; 5(2):121-49. PubMed ID: 38958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptics as a guideline to biological research in psychotic disorders.
    van Praag HM
    Compr Psychiatry; 1975; 16(1):7-22. PubMed ID: 1089049
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
    Havemann U
    Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.
    Baldessarini RJ; Tarsy D
    Annu Rev Neurosci; 1980; 3():23-41. PubMed ID: 6106450
    [No Abstract]   [Full Text] [Related]  

  • 16. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
    Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
    Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine receptor mechanisms: behavioral and electrophysiological studies.
    Ungerstedt U; Ljungberg T; Schultz W
    Adv Biochem Psychopharmacol; 1978; 19():311-21. PubMed ID: 29451
    [No Abstract]   [Full Text] [Related]  

  • 18. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
    Bartholini G
    Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
    Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
    Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopamine hypothesis of schizophrenia revisited.
    van Kammen DP
    Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.